Active Ingredient: TADALAFIL
Proprietary Name: TADALAFIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB2
Application Number: A212062
Product Number: 001
Approval Date: Mar 26, 2019
Applicant Holder Full Name: TORRENT PHARMACEUTICALS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
